News & Info
Coronavirus Assessment Tool
Get Care Virtually
See a Doctor
Coronavirus Blog & News
FDA grants full approval of Pfizer COVID-19 vaccine
The FDA granted full approval of Pfizer's COVID-19 vaccine for those ages 16 and up, validating the vaccine's safety. Learn more.
Keep kids healthy, safe with recommended vaccines
As you prepare to begin the school year, get the facts about what vaccines are required for kids and why.
What to know about the Delta variant
What you need to know now about the COVID-19 Delta variant. Providence experts weigh in. Learn more.
Breaking down barriers to vaccine hesitancy
The PSJH team is breaking through barriers of vaccine hesitancy in the OC Hispanic community by meeting this group right where they are. Here’s how.
Community Health Investment: New grant funds vaccine efforts
Learn how the newest grant to Community Health Investment, Providence Southern California, will help reach hard-hit communities about COVID-19 vaccinations.
Over 50? Add these vaccines to your to-do list.
Up-to-date vaccines and annual physical exams help people over 50 protect their health and their communities.
On the fence about getting your children vaccinated for COVID? Here are a few reasons to consider it
Parents must make deeply personal decisions about vaccinations for their children. Here are things to consider if you're on the fence about COVID-19 vaccines.
Pfizer vaccine now authorized for use in 12-15-year-olds
Providence offers insights about the FDA's approval of the COVID-19 vaccine for 12-15-year-olds.
Deciding whether to get the COVID vaccine? 5 facts you should know
Still undecided about the efficacy of the COVID vaccine? Here are 5 facts that we hope will help you decide. Learn more.
Kaiser, Providence and Medical Teams International partner in vaccine equity efforts
Portland’s first African American Baptist church, Mt. Olivet, has opened a temporary vaccination clinic, funded by Providence Health & Services and Kaiser Permanente.
Meet the long-haulers: Dealing with the lingering effects of COVID
Providence answers some burning questions about the long-term effects of COVID. Learn more.
I’m fully vaccinated. Can I socialize now?
The CDC recently published its first set of public health recommendations for activities fully vaccinated people can resume.
5 COVID-19 vaccine myths and the facts
Get fact-based information from public health and medical experts about the COVID-19 vaccine
The COVID-19 vaccine is here…now what?
The FDA-approved COVID-19 vaccine is starting to roll out. Learn how Providence is approaching the distribution of the vaccine.
Providence researchers demonstrate antibodies to COVID-19 in breast milk of mothers following vaccination
Learn about a potential immune benefit for infants from lactating mothers who have received a COVID-19 vaccine.
Will COVID-19 be the catalyst for creating a more sustainable healthcare system?
Providence Chief Medical Analytics Officer, Dr. Ari Robicsek offers insights on how pandemic created innovations in care delivery.
What you need to know about the new COVID-19 variants
Providence experts address questions about COVID-19 variants. Learn more.
Q&A with Dr. Anthony Fauci, this year’s Luminary Award winner
Dr. Lee Hood and Dr. Anthony Fauci discuss COVID-19 and lessons learned through the pandemic. Learn more.
How real-time data informs decision-making during COVID-19
Providence’s DetectionMap uses real-time data extracted from the EHR to show COVID-19 prevalence at the neighborhood level. Learn more.
Answering the call to serve during the COVID-19 crisis
How caregivers across Providence are stepping up to help those in need. Learn more.
Tips to prepare for your second COVID-19 shot
As you prepare to receive your second dose of COVID-19 vaccine, the following tips and reminders will improve your experience.
New coronavirus strain: What you need to know
A new coronavirus strain, first detected in the United Kingdom, has made its way to the U.S. with confirmed cases reported in several states.
Providence prepares for December COVID-19 vaccine distribution
At least two COVID-19 vaccines are expected to receive FDA emergency use authorization in a matter of days.